Integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific
To date, ekincare has raised a total funding of USD22M since 2015.;
ekincare, India's AI-powered integrated digital health gateway, has announced the raising of a strategic, undisclosed investment led by global healthcare leader MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) through MSD IDEA Studio Asia Pacific, an initiative by the MSD Global Health Innovation Fund (MGHIF).
The round also saw participation from ekincare’s existing investor, HealthQuad, a venture capital fund focused on healthcare innovation.
As per the release, the company stated, "This investment round will empower ekincare to advance its mission of revolutionizing corporate primary and preventive healthcare through AI-driven, personalized Outpatient Department (OPD) solutions. With this investment, ekincare aims to expand its cashless OPD network and enhance AI-powered analytics to drive better preventive care, chronic disease management, and employee wellness outcomes."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.